Previous Close | 25.95 |
Open | 25.95 |
Bid | 18.40 |
Ask | 18.75 |
Strike | 50.00 |
Expire Date | 2024-06-21 |
Day's Range | 25.95 - 25.95 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
Comprehensive Analysis of Gilead's First Quarter Financial Performance